Frontlight ResearchEarly access
Trial site
Guangzhou
- 8running trials
- 3closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Asthma2 trials
- COPD2 trials
- Haemophilia2 trials
- Bronchiectasis1 trial
- Crohn's disease1 trial
- Cystic fibrosis1 trial
- Hidradenitis suppurativa1 trial
- Multiple sclerosis1 trial
- Ulcerative colitis1 trial
- Phase
- Phase 26 trials
- Phase 34 trials
- Phase 41 trial
- Status
- Recruiting4 trials
- Active, not recruiting3 trials
- Completed3 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Sanofi10 trials
- Bioverativ, a Sanofi company1 trial
Running trials
Recruiting
Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
Recruiting
Recruiting
Recruiting
A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
Enrolling by invitation
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
Active, not recruiting
Active, not recruiting
Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- COPD2 recruiting
- Asthma1 recruiting
- Crohn's disease1 recruiting
- Hidradenitis suppurativa1 recruiting
Closed trials
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026